Environmental Factors in the Pathogenesis of Cardiovascular Diseases
Environmental conditions and processes are one of the major pillars on which the human well-being rests. It is the core responsibility of the society to preserve and enhance better conditions for the human well-being. Indeed, there are several evolving unmet needs in public health. Emerging and re-e...
Na minha lista:
| Autor Corporativo: | |
|---|---|
| Outros Autores: | , |
| Formato: | Recurso Electrónico livro electrónico |
| Idioma: | inglês |
| Publicado em: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2024.
|
| Edição: | 1st ed. 2024. |
| Colecção: | Advances in Biochemistry in Health and Disease,
30 |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/978-3-031-62806-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Sumário:
- Part 1. Introduction
- 1. Introduction Dragan M. Djuric and Devendra K. Agrawal (Serbia, US)
- 2. Human envirome and cardiovascular diseases Professor Kristina Gopcevic and Team (Serbia)
- Part2. Environmental Aspects in the Pathogenesis of Cardiovascular Diseases
- 3. Endocrine disruptors and cardiovascular diseases: a thinly veiled threat Professor Danina M. Muntean and Team (Romania)
- 4. Cardiovascular disease risk factors, immune checkpoints and Tregs Professor Xiaofeng Yang and Team (US)
- 5. Toxic effects of intracellular free zinc ion in cardiomyocytes via zinc-transporters: Structural and functional changes in mitochondria Professor Belma Turan and Team (Turkey)
- 6. Cardiovascular effects of acetylcholinesterase inhibitors Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina)
- 7. Cardiotoxic effects of catecholamines Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina)
- 8. Pathophysiological mechanisms of COVID infection in diabetes Professor Dinender K. Singla and Team (US)
- 9. Magnetic fields and cardiovascular health Professor Nina Japundzic Zigon and Team (Serbia)
- 10. Seasonality of cardiovascular diseases: Roles of natural and anthropogenic factors Professor Leonid P. Churilov and Team (Russia)
- 11. Environmental factors and CABG grafts: histophysiology and strategies for grafts patency rate improvement Professor Milica Labudovic Borovic and Team (Serbia)
- 12. Is homocysteine biomarker of epigenetic-DNA methylation and environmental health risk: Roles in cardiovascular pathophysiology and link with homocysteine-related vitamins? Professor Dragan M. Djuric and Team (Serbia)
- 13. Mental stressors and cardiovascular diseases Professor Antoinette Oliveira Blackman (Brazil)
- 14. Air pollution and the pathogenesis of CVD -to be determined
- 15. Water pollution and the pathogenesis of CVD -to be determined
- Part 3. Genetics and Nutritional Effects in the Pathogenesis of Cardiovascular Diseases
- 16. Interaction between Genetic Factors and Environmental Factors in the Pathogenesis of CVD Professor Devendra K. Agrawal and Team (US)
- 17. Nutrition, Gut Microbiota, and the Pathogenesis of Cardiovascular Diseases to be determined
- Part 4. Prevention of Environmental Factors-induced Cardiovascular Diseases
- 18. Recent trends and advancements in the pathogenesis and prevention of cardiovascular diseases: With special focus on the mitigation of oxidative stress, atherosclerosis, and gut microbiota-induced trimethylamine Professor Harpal Buttar and Team (Hungary)
- 19. The role of exercise in the CVD prevention Professor Dr. Maciej Banach (Poland)
- 20. Cardiovascular adaptation to exercise: from basic science to applied investigations Professor Vladimir Jakovljevic and Team (Serbia)
- 21. French paradox: a role for Akt activation Professor Ferenc Gallyas Jr, and Team (Hungary)
- Part 5. Treatment of Environmental Factors-induced Cardiovascular Diseases
- 22. Potential new drug targets modulating the environmentally induced oxidative stress in the cardiovascular system Professor Zoran Todorovic and Team (Serbia)
- 23. Critical Therapeutic Targets of Human Cardiac Infarction Pathology – Methods to Aid the Adult Hypoxic Heart Professor Ildiko Bock-Marquette and Team (Hungary)
- 24. Angiotensin Converting Enzyme-2 (ACE-2): A target for Novel Drug Development Professor Ramesh K. Goyal and Team (India)
- 25. The role of pharmacogenomics in drug-induced cardiovascular toxicity Professor Ranko Skrbic (Bosnia and Herzegovina)
- 26. Anti-inflammatory therapy and pleiotropic effects of drugs Professor Devendra K. Agrawal and Team (US).